A Retrospective Cohort Study of Clinical Characteristics and Outcomes of Type 2 Diabetic Patients with Kidney Disease

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2024 Feb 23

PMID 38390389

Authors

Xi He

Yuanjun Deng

Beichen Tian

Yixuan Zhao

Min Han

Yang Cai

Affiliations

Soon will be listed here.

Abstract

Background: Type 2 diabetes mellitus (T2DM) with chronic kidney disease (CKD) poses a serious health threat and becomes a new challenge. T2DM patients with CKD fall into three categories, diabetic nephropathy (DN), non-diabetic kidney disease (NDKD), and diabetic nephropathy plus non-diabetic kidney disease (DN + NDKD), according to kidney biopsy. The purpose of our study was to compare the clinical characteristics and kidney outcomes of DN, NDKD, and DN + NDKD patients.

Methods: Data on clinical characteristics, pathological findings, and prognosis were collected from June 2016 to July 2022 in patients with previously diagnosed T2DM and confirmed DN and or NDKD by kidney biopsy at Tongji Hospital in Wuhan, China. The endpoint was defined as kidney transplantation, dialysis, or a twofold increase in serum creatinine.

Results: In our 6-year retrospective cohort research, a total of 268 diabetic patients were admitted and categorized into three groups by kidney biopsy. The 268 patients were assigned to DN ( = 74), NDKD ( = 109), and DN + NDKD ( = 85) groups. The most frequent NDKD was membranous nephropathy (MN) ( = 45,41.28%). Hypertensive nephropathy was the most common subtype in the DN+NDKD group ( = 34,40%). A total of 34 patients (12.7%) reached the endpoint. The difference between the Kaplan-Meier survival curves of the DN, NDKD, and DN + NDKD groups was significant ( < 0.05). Multifactorial analysis showed that increased SBP [HR (95% CI): 1.018(1.002-1.035), = 0.025], lower Hb [HR(95% CI): 0.979(0.961-0.997), = 0.023], higher glycosylated hemoglobin [HR(95% CI): 1.338(1.080-1.658), = 0.008] and reduced serum ALB [HR(95% CI): 0.952(0.910-0.996), = 0.032] were risk factors for outcomes in the T2DM patients with CKD.

Conclusions: This research based on a Chinese cohort demonstrated that the risk of endpoint events differed among DN, NDKD, and DN+NDKD patients. In T2DM patients with CKD, DN patients displayed worse kidney prognosis than those with NDKD or DN + NDKD. Increased SBP, higher glycosylated hemoglobin, lower Hb, and decreased serum ALB may be correlated with adverse kidney outcomes in T2DM patients.

References

Byun J, Lee C, Lee S, Moon J, Lee S, Lee T . Renal outcomes and clinical course of nondiabetic renal diseases in patients with type 2 diabetes. Korean J Intern Med. 2013; 28(5):565-72. PMC: 3759762. DOI: 10.3904/kjim.2013.28.5.565. View

Wang J, Han Q, Zhao L, Zhang J, Wang Y, Wu Y . Identification of clinical predictors of diabetic nephropathy and non-diabetic renal disease in Chinese patients with type 2 diabetes, with reference to disease course and outcome. Acta Diabetol. 2019; 56(8):939-946. DOI: 10.1007/s00592-019-01324-7. View

Horvatic I, Tisljar M, Kacinari P, Matesic I, Bulimbasic S, Ljubanovic D . Non-diabetic renal disease in Croatian patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014; 104(3):443-50. DOI: 10.1016/j.diabres.2014.03.016. View

Liu S, Guo Q, Han H, Cui P, Liu X, Miao L . Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases. Int Urol Nephrol. 2016; 48(10):1691-8. PMC: 5031732. DOI: 10.1007/s11255-016-1331-y. View

Yamanouchi M, Furuichi K, Shimizu M, Toyama T, Yamamura Y, Oshima M . Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study. Nephrol Dial Transplant. 2021; 37(3):489-497. DOI: 10.1093/ndt/gfab185. View

Efremova I, Maslennikov R, Poluektova E, Zharkova M, Kudryavtseva A, Krasnov G . Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis. Microorganisms. 2023; 11(9). PMC: 10537778. DOI: 10.3390/microorganisms11092202. View

Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K . Microvascular Complications of Type 2 Diabetes Mellitus. Curr Vasc Pharmacol. 2019; 18(2):117-124. DOI: 10.2174/1570161117666190502103733. View

Li M, Li C, Ye Z, Rao J, Peng H, Lou T . A retrospective cohort study on the pathology and outcomes of type 2 diabetic patients with renal involvement. Int Urol Nephrol. 2020; 53(2):333-341. DOI: 10.1007/s11255-020-02657-x. View

Zhang J, Wang Y, Zhang R, Li H, Han Q, Guo R . Implication of decreased serum complement 3 in patients with diabetic nephropathy. Acta Diabetol. 2017; 55(1):31-39. DOI: 10.1007/s00592-017-1060-4. View

10.

Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, Haring H . The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol. 2016; 12(12):721-737. DOI: 10.1038/nrneph.2016.145. View

11.

Tsai S, Tarng D . Anemia in patients of diabetic kidney disease. J Chin Med Assoc. 2019; 82(10):752-755. DOI: 10.1097/JCMA.0000000000000175. View

12.

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan B . IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2021; 183:109119. PMC: 11057359. DOI: 10.1016/j.diabres.2021.109119. View

13.

Mubarak M, Kazi J . IgM nephropathy revisited. Nephrourol Mon. 2013; 4(4):603-8. PMC: 3614302. DOI: 10.5812/numonthly.2805. View

14.

Sun Y, Ren Y, Lan P, Yu X, Feng J, Hao D . Clinico-pathological features of diabetic and non-diabetic renal diseases in type 2 diabetic patients: a retrospective study from a 10-year experience in a single center. Int Urol Nephrol. 2023; 55(9):2303-2312. PMC: 10406681. DOI: 10.1007/s11255-023-03478-4. View

15.

Anderson A, Xie D, Wang X, Baudier R, Orlandi P, Appel L . Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2020; 77(1):56-73.e1. PMC: 7752839. DOI: 10.1053/j.ajkd.2020.07.011. View

16.

Aldebeyan S, Nooh A, Aoude A, Weber M, Harvey E . Hypoalbuminaemia-a marker of malnutrition and predictor of postoperative complications and mortality after hip fractures. Injury. 2017; 48(2):436-440. DOI: 10.1016/j.injury.2016.12.016. View

17.

Zhang W, Liu X, Dong Z, Wang Q, Pei Z, Chen Y . New Diagnostic Model for the Differentiation of Diabetic Nephropathy From Non-Diabetic Nephropathy in Chinese Patients. Front Endocrinol (Lausanne). 2022; 13:913021. PMC: 9279696. DOI: 10.3389/fendo.2022.913021. View

18.

Saini D, Kochar A, Poonia R . Clinical correlation of diabetic retinopathy with nephropathy and neuropathy. Indian J Ophthalmol. 2021; 69(11):3364-3368. PMC: 8725070. DOI: 10.4103/ijo.IJO_1237_21. View

19.

Cheng T, Wang X, Han Y, Hao J, Hu H, Hao L . The level of serum albumin is associated with renal prognosis and renal function decline in patients with chronic kidney disease. BMC Nephrol. 2023; 24(1):57. PMC: 10018824. DOI: 10.1186/s12882-023-03110-8. View

20.

Pallayova M, Mohammed A, Langman G, Taheri S, Dasgupta I . Predicting non-diabetic renal disease in type 2 diabetic adults: The value of glycated hemoglobin. J Diabetes Complications. 2015; 29(5):718-23. DOI: 10.1016/j.jdiacomp.2014.12.005. View